Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation.
Ischemia-modified albumin (IMA), measured with the albumin cobalt binding test, is a marker of myocardial ischemia. We measured IMA concentrations after elective direct-current cardioversion for atrial fibrillation to determine whether transient myocardial ischemia occurs. Patients with electrocardiographic changes after cardioversion (ST-depression and/or T-wave inversion) had significantly higher IMA levels than those without these changes. Thus, elevated levels of IMA after cardioversion may reflect transient myocardial ischemia.
Roy
Debashis
D
Department of Cardiological Sciences, St. George's Hospital Medical School, Cranmer Terrace, London, United Kingdom.
Quiles
Juan
J
Sinha
Manas
M
Aldama
Guillermo
G
Gaze
David
D
Kaski
Juan Carlos
JC
D000368:Aged; D001281:Atrial Fibrillation / Q000097:blood / Q000628:therapy*; D003035:Cobalt / Q000378:metabolism; D004554:Electric Countershock / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood* / Q000209:etiology*; D011485:Protein Binding; D012709:Serum Albumin / Q000378:metabolism*
D012709:Serum Albumin; D003035:Cobalt